Skip to main content
Partner NL

Dutch Cancer Society

DCS
DCS logo

Organisation

Acronym
DCS
Role
Partner
Country
NL
Address
Delflandlaan 171062 EA Amsterdam
Website
https://www.kwf.nl/

Programme phases

1

Funding participation

Joint calls funded by this organisation.

5

Funded projects

Projects linked to this funding organisation.

29
ABC-Cancer

Airborne Biomarkers for Colorectal Cancer

JTC 2016
View project
ARREST

Approaching recurrence and resistance mechanisms in esophagogastric adenocarcinomas from the prospective MEMORI trial

JTC 2014
View project
BioEndoCar

Biomarkers for diagnosis and prognosis of endometrial carcinoma

JTC 2016
View project
BRCAddict

BRCAddict – Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors

JTC 2017
View project
CCE Breast

Clinical Impact of Intratumor heterogeneity in metastatic breast cancer

JTC 2014
View project
CLEARLY

Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection.

JTC 2016
View project
ESCEND

Detection of Early esophageal cancer by near-infrared fluorescence molecular endoscopy

JTC 2016
View project
EuroTCLym

Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets

JTC 2017
View project
FAMILIAL CANCER

Cancer prevention through improved familial risk assessment and gene discovery

JTC 2012
View project
FOCUS

Biomarkers related to folate-dependent one-carbon metabolism in CRC recurrence and survival

JTC 2013
View project
GENMEL

Identification of genetic markers involved in development of metastases and second cancers in melanoma

JTC 2013
View project
IMMUNOSCOR

Integrative cancer-immunology and Immunoscore for cancer classification and immunotherapies

JTC 2013
View project
INTRACOLOR

Evolution of resistant clones to novel target-directed drugs in colorectal tumors. - A genetic and epigenetic study of intratumoral heterogeneity dynamics

JTC 2014
View project
ITEM

Dissecting phenotypic heterogeneity of human melanoma: building a rationale for active immunotherapies overcoming immunologically-induced dedifferentiation.

JTC 2014
View project
LIQUIDHOPE

Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastoma

JTC 2017
View project
Ma.Tr.OC

Identification of molecular therapeutic targets and diagnostic/prognostic biomarkers for Malignant Transformation of Osteochondromas

JTC 2012
View project
MesaCapp

Mesalamine for Colorectal Cancer Prevention Program in Lynch syndrome

JTC 2012
View project
MetaboCCC

Metabolomic profiles throughout the continuum of colorectal cancer

JTC 2012
View project
MOLCARUTUC

Comprehensive genomic characterization of upper urinary tract urothelial carcinoma and paired bladder recurrences

JTC 2017
View project
NIRBTEST

New strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles.

JTC 2016
View project
NOVEL

Employing NGS technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients

JTC 2016
View project
PROMETOV

Proteogenomic and targeted metabolomic analysis of ovarian cancer heterogeneity and its contribution to recurrence and therapy resistance.

JTC 2014
View project
PROSCANEXO

Exploitation of extracellular vesicles for precision diagnostics of prostate cancer

JTC 2016
View project
TACTIC

TArgeting Colon Tumor Initiating Cell heterogeneity

JTC 2014
View project
TOPMESO

A TranslatiOnal Platform for de-orphaning malignant pleural MESOthelioma

JTC 2017
View project
TORPEDO

Targeting Of Resistance in PEDiatric Oncology (TORPEDO)

JTC 2014
View project
TRANsIBCCS

Development of a Comprehensive Risk Prediction Model for BRCA1 and BRCA2 mutation carriers

JTC 2012
View project
Triage-MDS

TRanslational Implementation of Genetic Evidence in the management of MDS

JTC 2012
View project